BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 11689482)

  • 1. Gene replacement therapy in the retinal degeneration slow (rds) mouse: the effect on retinal degeneration following partial transduction of the retina.
    Sarra GM; Stephens C; de Alwis M; Bainbridge JW; Smith AJ; Thrasher AJ; Ali RR
    Hum Mol Genet; 2001 Oct; 10(21):2353-61. PubMed ID: 11689482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy.
    Ali RR; Sarra GM; Stephens C; Alwis MD; Bainbridge JW; Munro PM; Fauser S; Reichel MB; Kinnon C; Hunt DM; Bhattacharya SS; Thrasher AJ
    Nat Genet; 2000 Jul; 25(3):306-10. PubMed ID: 10888879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term evaluation of retinal function in Prph2Rd2/Rd2 mice following AAV-mediated gene replacement therapy.
    Schlichtenbrede FC; da Cruz L; Stephens C; Smith AJ; Georgiadis A; Thrasher AJ; Bainbridge JW; Seeliger MW; Ali RR
    J Gene Med; 2003 Sep; 5(9):757-64. PubMed ID: 12950066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic but not intraocular Epo gene transfer protects the retina from light-and genetic-induced degeneration.
    Rex TS; Allocca M; Domenici L; Surace EM; Maguire AM; Lyubarsky A; Cellerino A; Bennett J; Auricchio A
    Mol Ther; 2004 Nov; 10(5):855-61. PubMed ID: 15509503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospects for gene therapy.
    Ali RR
    Novartis Found Symp; 2004; 255():165-72; discussion 173-8. PubMed ID: 14750603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diurnal metabolism of dopamine in dystrophic retinas of homozygous and heterozygous retinal degeneration slow (rds) mice.
    Nir I; Haque R; Iuvone PM
    Brain Res; 2000 Nov; 884(1--2):13-22. PubMed ID: 11082482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late-onset cone photoreceptor degeneration induced by R172W mutation in Rds and partial rescue by gene supplementation.
    Conley S; Nour M; Fliesler SJ; Naash MI
    Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5397-407. PubMed ID: 18055786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photoreceptor peripherin is the normal product of the gene responsible for retinal degeneration in the rds mouse.
    Connell G; Bascom R; Molday L; Reid D; McInnes RR; Molday RS
    Proc Natl Acad Sci U S A; 1991 Feb; 88(3):723-6. PubMed ID: 1992463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The retinal degeneration slow (rds) gene product is a photoreceptor disc membrane-associated glycoprotein.
    Travis GH; Sutcliffe JG; Bok D
    Neuron; 1991 Jan; 6(1):61-70. PubMed ID: 1986774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa.
    Portera-Cailliau C; Sung CH; Nathans J; Adler R
    Proc Natl Acad Sci U S A; 1994 Feb; 91(3):974-8. PubMed ID: 8302876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and analysis of transgenic mice expressing P216L-substituted rds/peripherin in rod photoreceptors.
    Kedzierski W; Lloyd M; Birch DG; Bok D; Travis GH
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):498-509. PubMed ID: 9040483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa.
    Liang FQ; Aleman TS; Dejneka NS; Dudus L; Fisher KJ; Maguire AM; Jacobson SG; Bennett J
    Mol Ther; 2001 Nov; 4(5):461-72. PubMed ID: 11708883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Bcl-2 protects against photoreceptor degeneration in retinal degeneration slow (rds) mice.
    Nir I; Kedzierski W; Chen J; Travis GH
    J Neurosci; 2000 Mar; 20(6):2150-4. PubMed ID: 10704489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactose promotes organized photoreceptor outer segment assembly and preserves expression of photoreceptor proteins in retinal degeneration.
    Jablonski MM; Wohabrebbi A; Ervin CS
    Mol Vis; 1999 Aug; 5():16. PubMed ID: 10449803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In contrast to AAV-mediated Cntf expression, AAV-mediated Gdnf expression enhances gene replacement therapy in rodent models of retinal degeneration.
    Buch PK; MacLaren RE; DurĂ¡n Y; Balaggan KS; MacNeil A; Schlichtenbrede FC; Smith AJ; Ali RR
    Mol Ther; 2006 Nov; 14(5):700-9. PubMed ID: 16872907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraocular gene delivery of ciliary neurotrophic factor results in significant loss of retinal function in normal mice and in the Prph2Rd2/Rd2 model of retinal degeneration.
    Schlichtenbrede FC; MacNeil A; Bainbridge JW; Tschernutter M; Thrasher AJ; Smith AJ; Ali RR
    Gene Ther; 2003 Mar; 10(6):523-7. PubMed ID: 12621456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The spectrum of retinal dystrophies caused by mutations in the peripherin/RDS gene.
    Boon CJ; den Hollander AI; Hoyng CB; Cremers FP; Klevering BJ; Keunen JE
    Prog Retin Eye Res; 2008 Mar; 27(2):213-35. PubMed ID: 18328765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripherin/rds influences membrane vesicle morphology. Implications for retinopathies.
    Wrigley JD; Ahmed T; Nevett CL; Findlay JB
    J Biol Chem; 2000 May; 275(18):13191-4. PubMed ID: 10747861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of neuronal visual responses in the superior colliculus in Prph2(Rd2/Rd2) mice following gene therapy.
    Schlichtenbrede FC; Smith AJ; Bainbridge JW; Thrasher AJ; Salt TE; Ali RR
    Mol Cell Neurosci; 2004 Jan; 25(1):103-10. PubMed ID: 14962744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulating expression of peripherin/rds in transgenic mice: critical levels and the effect of overexpression.
    Nour M; Ding XQ; Stricker H; Fliesler SJ; Naash MI
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2514-21. PubMed ID: 15277471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.